Bronchial artery revascularization in lung transplantation: a systematic review and meta-analysis

Journal of Thoracic Disease

article

Howard T. Massey¹  Richard C. Daly²  Vakhtang Tchantchaleishvili¹  Danial Ahmad¹  Thomas J. O'Malley¹  Andrew M. Jordan¹  Elizabeth J. Maynes¹  Abhiraj Saxena¹  Kyle W. Prochno¹  Taufiek K. Rajab³ 

[1] Division of Cardiac Surgery, Thomas Jefferson University;Department of Cardiovascular Surgery, Mayo Clinic;Division of Cardiothoracic Surgery, Medical University of South Carolina

关键词: Lung transplant;    bronchial artery revascularization (BAR);    bronchiolitis obliterans syndrome (BOS);   

DOI  :  10.21037/jtd-22-213

学科分类：呼吸医学

来源: Pioneer Bioscience Publishing Company

【 摘 要 】

Background: Bronchial artery revascularization (BAR) during lung transplantation has been hypothesized to improve early tracheal healing and delay the onset of bronchiolitis obliterans syndrome (BOS). We aimed to assess the outcomes of BAR after lung transplantation. Methods: Electronic search in Ovid Medline, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Scopus, and Cochrane Controlled Trials Register (CCTR) databases was performed to identify all relevant studies published about lung transplantation with BAR. Studies discussing lung transplantation utilizing BAR were included while those without outcome data such as BOS and survival were excluded. Cohort-level data were extracted and pooled for analysis. A binary outcome meta-analysis of proportions with logit transformation was conducted. Newcastle-Ottawa scale was used for risk of bias assessment. Results: Seven studies were selected for the analysis comprising 143 patients. Mean patient age was 47 (95% CI: 40–55) years. Sixty-one percent (48–72%) were male. Seventy-three percent (65–79%) of patients underwent double lung transplant while 27% (21–25%) underwent single lung transplant. In patients with postoperative angiography, successful BAR was demonstrated in 93% (82–97%) of all assessed conduits. The 30-day/in-hospital mortality was 6% (3–11%). Seventy-nine percent (63–89%) of patients were free from rejection at three months. Eighty-three percent (29–98%) of patients were free from signs of airway ischemia at three and six months. Pooled survival at one year and five years was 87% (78–92%) and 71% (46–87%), respectively, with a mean follow-up time of 21 (3–38) months. Pooled freedom from bronchiolitis obliterans was 86% (77–91%) at two years. Conclusions: While this systematic review and meta-analysis is limited by the available surgeons, institutions, and papers discussing a highly specialized technique, it does show that BAR is a viable technique to minimize BOS and early anastomotic intervention following lung transplantation.

【 授权许可】

Unknown